Based on our findings, only the IPI, BCL6 expression by IHC, and high (>90%) MIB-1 expression and not the other markers analyzed (CD10, BCL2, MUM1, MYC positivity, and gender) are independent predictors of OS and EFS in DLBCL. The gene discussed is MIB1; the disease is diffuse large B-cell lymphoma.